Corvus Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Corvus Pharmaceuticals, Inc. (CRVS) reported Earnings Per Share, Basic and Diluted of -$0.24 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-01
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.24.
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.28.
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.34.
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was $0.92.
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.20.
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.59.
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.71.
- Corvus Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2017 was -$2.72.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 11 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | -$0.24 10-Q · filed 2021-11-01 | -$0.84 10-Q · filed 2021-11-01 | |||
| 2021-06-30 | -$0.28 10-Q · filed 2021-08-02 | -$0.61 10-Q · filed 2021-08-02 | |||
| 2021-03-31 | -$0.34 10-Q · filed 2021-04-29 | ||||
| 2020-12-31 | $0.92 10-K · filed 2021-03-25 | -$0.20 10-K · filed 2021-03-25 | |||
| 2020-09-30 | -$0.33 10-Q · filed 2021-11-01 | -$1.13 10-Q · filed 2021-11-01 | |||
| 2020-06-30 | -$0.36 10-Q · filed 2021-08-02 | -$0.80 10-Q · filed 2021-08-02 | |||
| 2020-03-31 | -$0.44 10-Q · filed 2021-04-29 | ||||
| 2019-12-31 | -$0.38 10-K · filed 2021-03-25 | -$1.59 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$0.37 10-K · filed 2021-03-25 | -$1.21 10-Q · filed 2020-10-29 | |||
| 2019-06-30 | -$0.44 10-K · filed 2021-03-25 | -$0.84 10-Q · filed 2020-07-30 | |||
| 2019-03-31 | -$0.40 10-K · filed 2021-03-25 | ||||
| 2018-12-31 | -$0.36 10-K · filed 2020-03-09 | -$1.71 10-K · filed 2021-03-25 | |||
| 2018-09-30 | -$0.36 10-K · filed 2020-03-09 | -$1.35 10-Q · filed 2019-10-29 | |||
| 2018-06-30 | -$0.40 10-K · filed 2020-03-09 | -$1.01 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | -$0.63 10-K · filed 2020-03-09 | ||||
| 2017-12-31 | -$0.58 10-K · filed 2019-03-07 | -$2.72 10-K · filed 2020-03-09 | |||
| 2017-09-30 | -$0.62 10-K · filed 2019-03-07 | -$2.14 10-Q · filed 2018-11-01 | |||
| 2017-06-30 | -$0.73 10-K · filed 2019-03-07 | -$1.52 10-Q · filed 2018-08-02 | |||
| 2017-03-31 | -$0.79 10-K · filed 2019-03-07 | ||||
| 2016-12-31 | -$0.55 10-K · filed 2018-03-01 | -$2.36 10-K · filed 2019-03-07 | |||
| 2016-09-30 | -$0.51 10-K · filed 2018-03-01 | -$1.83 10-Q · filed 2017-11-02 | |||
| 2016-06-30 | -$0.43 10-K · filed 2018-03-01 | -$1.42 10-Q · filed 2017-08-03 | |||
| 2016-03-31 | -$5.39 10-K · filed 2018-03-01 | ||||
| 2015-12-31 | -$13.31 10-K · filed 2017-03-10 | -$83.86 10-K · filed 2018-03-01 | |||
| 2015-09-30 | -$7.97 10-K · filed 2017-03-10 | -$72.98 10-Q · filed 2016-11-03 | |||
| 2015-06-30 | -$58.42 10-K · filed 2017-03-10 | -$68.80 10-Q · filed 2016-08-04 | |||
| 2015-03-31 | -$6.44 10-K · filed 2017-03-10 | ||||
| 2014-12-31 | -$0.95 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |